Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis

Sodium glucose transporter 2 (SGLT2) inhibitors are a recently developed class of drug that have been approved for use in type 2 diabetes. Their unique extra-pancreatic glucuretic mode of action has encouraged their usage in type 1 diabetes as well. At the same time, reports of pseudo ketoacidosis a...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Rakesh Sahay, Yashdeep Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Canagliflozin
dapagliflozin
empagliflozin
good clinical sense
ketoacidosis
ketonuria
type 1 diabetes
type 2 diabetes
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=4;spage=524;epage=528;aulast=Kalra

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=4;spage=524;epage=528;aulast=Kalra

Similar Items